Search results for "OLDER"

showing 10 items of 1264 documents

Erratum to: Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty

2016

Background Frailty is highly prevalent in elderly people. While significant progress has been made to understand its pathogenesis process, few validated questionnaire exist to assess the multidimensional concept of frailty and to detect people frail or at risk to become frail. The objectives of this study were to construct and validate a new frailty-screening instrument named Frailty Groupe Iso-Ressource Evaluation (FRAGIRE) that accurately predicts the risk for frailty in older adults. Methods A prospective multicenter recruitment of the elderly patients was undertaken in France. The subjects were classified into financially-helped group (FH, with financial assistance) and non-financially …

Older personGerontologyRehabilitationFrailtybusiness.industryGeriatrics gerontologymedicine.medical_treatmentPublished ErratumMEDLINEEvaluation toolLoss of autonomy03 medical and health sciencesElderly0302 clinical medicinemedicine030212 general & internal medicineGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryResearch ArticleBMC Geriatrics
researchProduct

Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications

2021

Abstract BACKGROUND: Midostaurin is a first-generation, type I multi-targeted kinase inhibitor with inhibitory activity against FLT3-ITD and -TKD mutations. Midostaurin is approved by FDA and EMA in combination with intensive induction and consolidation chemotherapy for adult patients with AML exhibiting an activating FLT3 mutation; the EMA label also includes single-agent maintenance therapy following consolidation chemotherapy. We conducted a phase-II trial (AMLSG 16-10) to evaluate midostaurin with induction chemotherapy followed by allogeneic hematopoietic-cell transplantation (HCT) and a one-year midostaurin maintenance therapy in younger and older patients with acute myeloid leukemia …

Oncology0303 health sciencesmedicine.medical_specialtybusiness.industryImmunologyMyeloid leukemiaCell BiologyHematologyIntensive chemotherapyBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOlder patientschemistryInternal medicinemedicineMidostaurinbusiness030304 developmental biology030215 immunologyBlood
researchProduct

Special Situations in APL

2017

The introduction of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) as the mainstay therapy of acute promyelocytic leukemia (APL) has drastically changed the outcome of this hematologic malignancy into one of the first to receive a targeted treatment. Using frontline treatment strategies including these agents in combination with standard cytotoxic drugs has provided outstanding therapeutic results in most patients. In spite of the achievement of brilliant results in the majority of patients, some special situations still require the implementation of changes from the conventional therapeutic approach. In this chapter, we will review and discuss the management of APL in older and …

OncologyAcute promyelocytic leukemiamedicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseLeukemiachemistry.chemical_compoundTherapeutic approachchemistryOlder patientsInternal medicinemedicineHematologic malignancyTreatment strategyArsenic trioxidebusiness
researchProduct

Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?

2015

Treatment side effects, comorbidities, and guideline-adherent treatment (GL+) influence the oncologic outcome of older breast cancer patients (oBCP) (age ≥ 70 years). The focus of this analysis was to investigate the associations among tumor characteristics, guideline adherence, and outcome and to compare these associations between younger breast cancer patients (yBCP) (age 50-69 years) and oBCP.This is a retrospective multicenter cohort study with 17 participating certified breast cancer centers. The analysis of 10,897 patient records collected from 1992 to 2008 for GL+ and clinical outcome was performed. Tumor and patient characteristics and their associations with GL+ were compared betwe…

OncologyCancer Researchmedicine.medical_specialtyPatient characteristicsBreast NeoplasmsHER2/neuCohort StudiesBreast cancerOlder patientsInternal medicinemedicineHumansStage (cooking)AgedRetrospective StudiesGynecologybiologybusiness.industryGuideline adherenceMiddle Agedmedicine.diseaseOncologyPractice Guidelines as Topicbiology.proteinFemaleGuideline AdherencebusinessTamoxifenmedicine.drugCohort studyClinical Breast Cancer
researchProduct

P-42 Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies as treatment option in vulnerable older patients with metastatic colorec…

2021

Oncologymedicine.medical_specialtyChemotherapybiologybusiness.industryColorectal cancermedicine.medical_treatmentTreatment optionsRetrospective cohort studyHematologymedicine.diseaseReduced doseOncologyOlder patientsInternal medicinebiology.proteinMedicineAntibodybusinessAnnals of Oncology
researchProduct

Public sector reputation and netpromoter score

2021

AbstractReputation of public sector organizations is increasingly formed through Word of Mouth (WOM) as citizens and stakeholders share their experiences with others both online and offline. Understanding and measuring WOM is a challenge for many public sector organizations, who often resort to measurement tools designed for the private sector. This paper looks at a popular WOM measurement tool, namely the Net Promoter Score (NPS) in the context of public sector organizations. In this paper, we ask how well does the NPS describe public sector reputation, and look at what the different stakeholder groups categorized by NPS are like in the public sector. As an illustrative case, we report fin…

Online and offlineEconomics and Econometricsmedia_common.quotation_subjectWord of mouthkyselytutkimusContext (language use)NPSNet Promoter0502 economics and business050602 political science & public administrationMarketingsidosryhmätmedia_commonMarketingbusiness.industry05 social sciencesPublic sectorpalauteStakeholderNet Promoter ScorePrivate sectorjulkinen sektorimaineenhallinta0506 political sciencemaine050211 marketingBusinessReputation
researchProduct

A multi-perspective knowledge-driven approach for analysis of the demand side of the Open Government Data portal

2021

Abstract Open data are freely available and can be used by every stakeholder for its own purposes. However, the practice demonstrates that it is important to ensure that the source from which they are available is usable and facilitates the re-use of data to the widest possible range of stakeholders. This task is carried out by open government data (OGD) portals. Therefore, this study proposes a multi-perspective approach where an OGD portal is analyzed from (1) citizens' perspective, (2) users' perspective, (3) experts' perspective, and (4) state of the art. By considering these perspectives, we can define how to improve the portal in question by focusing on its demand side. In view of the…

Open governmentSociology and Political ScienceComputer sciencebusiness.industrymedia_common.quotation_subjectStakeholderUsabilityLibrary and Information SciencesReuseUSableData scienceTask (project management)Open dataQuality (business)businessLawmedia_commonGovernment Information Quarterly
researchProduct

Does Longer Leukocyte Telomere Length and Higher Physical Fitness Protect Master Athletes From Consequences of Coronavirus (SARS-CoV-2) Infection?

2020

Opinion2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)older athleteSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical fitnesscoronavirusmedicine.disease_causelcsh:GV557-1198.995MedicineCoronavirusinfektiotauditlcsh:Sportsbiologyvalkosolutbusiness.industryAthletesagingquarantineCOVID-19General Medicinebiology.organism_classificationVirologytelomere attritionTelomereimmune systemfyysinen kuntoSports and Active LivingtelomeeritSevere acute respiratory syndrome coronavirusbusinessikääntyneeturheilijatFrontiers in sports and active living
researchProduct

Opportunity costs and efficiency of investments in mega sport events

2009

Economic analyses of mega sport events usually focus on the positive effects and legacies while ignoring opportunity costs and the efficiency of using scarce resources. Event opponents argue that decisions to invest public resources should also consider alternative uses of the money. This paper aims to clarify some of the issues surrounding the opportunity costs of mega sport events. By using the measure ‘efficiency’ (output/input) of alternative investments it will become clear that the decision to stage a mega sport event cannot be taken in isolation and that there are many factors that need to be considered. The argument put forward is based on a stakeholder’s perspective and a spatial d…

Opportunity costEvent (computing)media_common.quotation_subjectWelfare economicsGeography Planning and DevelopmentStakeholderMega-Investment (macroeconomics)ScarcityEconomyArgumentTourism Leisure and Hospitality ManagementAlternative investmentBusinessmedia_commonJournal of Policy Research in Tourism, Leisure and Events
researchProduct

The Impact of Bank Concentration on Financial Distress: The Case of the European Banking System

2009

This paper examines the impact of bank concentrationon bank financial distress using a balanced panel of commercial banks in the EU‐25 over a sample period running from 2003 to 2007. Financial distress is proxied by the observations falling below a given threshold of the empirical distribution of a risk‐adjusted indicator of bank performance: the Shareholder Value Ratio. We employ a panel probit regression estimated by GMM in order to obtain consistent and efficient estimates, following the suggestion made by Bertschek and Lechner (1998). After controlling for a number of environment variables, we conclude that our findings suggest a positive effect of bank concentration on financial distre…

Order (exchange)Financial economicsProbit modelEconometricsFinancial distressSample (statistics)BusinessShareholder valueEmpirical distribution functionSSRN Electronic Journal
researchProduct